Phaseline

Targets › PBPS

PBPS: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Cardiovascular; next expected readout Jul 2027.

Open in Phaseline: the race on PBPS, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Fundación Pública Andaluza para la gestión de la Investigación en SevillaAmpicillin
Bacterial penicillin-binding protein inhibitor
PBPSPhase 4Endocarditis, InfectiveJul 2027

Conditions

Endocarditis, Infective (1)

Modalities

small molecule (1)

Companies

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.